The company was created in 2017 with the aim of developing a medical device to improve treatments for kidney disease.
Renalyse has raised €1.0M across 1 funding round from 1 investor, most recently a round in Oct 2023. Based in Terragona, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-10-12 | Other | €1.0M |
| Mind the Gap |
| View deal → |
